Abbott – A Promise for Life

  • 29 July 2013 at 06:49
  • abbott-logoAbbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries                                                                                     and employs approximately 70,000 people.

    A Wide-Ranging Presence in Diagnostics
    In diagnostics, Abbott is well positioned, with global leadership in in vitro diagnostics, which includes immunoassay, clinical chemistry, hematology, molecular, point-of-care, and informatics. In its largest segment of the market, core laboratory and blood screening, Abbott offers a broad range of innovative instrument systems and tests, as well as informatics and automation solutions for hospitals, reference labs, blood banks, physician offices and clinics. Our advanced diagnostic solutions help physicians provide diagnosis and management of many medical conditions including cardiac disease, diabetes, and infectious disease.
    Our ARCHITECT integrated analyzers provide immunoassay and clinical chemistry results for cardiac disease, cancer, endocrinology, fertility, infectious disease and other conditions. The CELL-DYN series, which is our premier hematology system, is used to perform sophisticated blood cell analysis to help physicians diagnose blood diseases and disorders. And our fully-automated Abbott PRISMnEXT blood-screening system consolidates high-volume testing into a single system, reducing the risk of accidents and errors and helping to ensure the safety of the blood supply.
    Molecular and point-of-care systems round out our diagnostic offerings. Abbott is a leader in the rapidly growing area of molecular diagnostics and the advancing field of personalized medicine. Our tests are designed to detect subtle, but key, differences in patients’ genes and chromosomes, which can assist physicians in the identification of disease, the selection of appropriate therapies and the monitoring of conditions. Abbott Point of Care products provide healthcare professionals immediate access to accurate, critical diagnostic test results at the point of patient care. Our i-STAT hand-held analyzer, the industry’s leading point-of-care system, lets physicians make treatment decisions at the patient’s bedside, speeding care in emergency departments, operating rooms, and critical care units.

    Abbott at the EAHM 24th Congress in Luxembourg
    We are looking forward to meeting you at our booth during the EAHM Congress in Luxembourg and to partnering with you in times of crisis – by providing innovative services and solutions that help you to increase operational efficiency, and optimize your economic situation while maintaining quality and patient care.